Arsenic-tainted drinking water may increase diabetes risk

January 11, 2018, American Physiological Society
Credit: CC0 Public Domain

A new study reports that chronic exposure to arsenic interferes with insulin secretion in the pancreas, which may increase the risk of diabetes. The paper, published ahead of print in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology.

Arsenic is an element that occurs naturally in soil, plants and water in small amounts. Long-term exposure to higher levels of environmental has been linked to cancer, heart disease, and other health problems and ingestion of large doses can be lethal. The World Health Organization estimates that millions of people around the globe—including in the U.S.—are exposed to unsafe levels of in their water supply. While sub-toxic levels of arsenic may not be fatal, they can still be dangerous, and researchers suggest "the metabolic risk imposed by arsenic is likely underestimated."

The research team studied male mice exposed to sub-toxic levels of arsenic to simulate chronic exposure to arsenic-contaminated drinking water. When compared with a control group, the arsenic-exposed mice exhibited higher due to reduced during the early phases of a glucose tolerance test. Insulin is the primary hormone responsible for transporting glucose out of the blood and into body tissues. Impairments in insulin secretion play a central role in the development of diabetes. Despite the reduced levels of insulin released after , however, the researchers found no significant differences in inflammation of the pancreas or the number of insulin-producing cells (beta cells) in the pancreas that are known to promote the development of diabetes. Unlike in type 1 diabetes, in which insulin production is limited because beta cells are destroyed, "arsenic induces glucose intolerance through a disruption of beta-cell function that alters normal stimulus–secretion coupling," the researchers wrote. Learning how arsenic changes the signaling for secretion is important to exploring future strategies for reducing diabetes risk, the research team explained. Furthermore, these findings suggest that arsenic-induced diabetes risk may be reversible if policies are enacted to reduce environmental exposure.

Explore further: Arsenic levels higher in patients with nonmelanoma skin cancers

More information: Andrew G. Kirkley et al. Arsenic Exposure Induces Glucose Intolerance and Alters Global Energy Metabolism, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (2017). DOI: 10.1152/ajpregu.00522.2016

Related Stories

Arsenic levels higher in patients with nonmelanoma skin cancers

August 22, 2017
(HealthDay)—Certain arsenic species levels are higher among patients with nonmelanoma skin cancer (NMSC), according to a study published online Aug. 16 in the Journal of Dermatology.

Arsenic metabolism linked to development of type 1 diabetes

November 22, 2016
(HealthDay)—Arsenic metabolism seems to be associated with type 1 diabetes in young people, with a potential interaction by folate levels, according to a study published online Nov. 11 in Diabetes Care.

Certain genes when exposed to the environment may lead to diabetes

August 5, 2015
Arsenic, which can be present in ground water, modifies an enzyme that alters the secretion of insulin in the pancreas.

Insulin release is controlled by the amount of Epac2A at the secretory vesicles

July 7, 2017
Specialized beta cells in the pancreas release the hormone insulin to control our blood glucose levels, and failure of this mechanism is central to the development of type-2 diabetes. How much and when insulin is released ...

Recommended for you

Implantable islet cells come with their own oxygen supply

April 25, 2018
Since the 1960s, researchers have been interested in the possibility of treating type 1 diabetes by transplanting islet cells—the pancreatic cells that are responsible for producing insulin when blood glucose concentration ...

Study shows drug effectiveness in reducing glucocorticoid-induced bone loss

April 25, 2018
About one in every 100 people in the world takes glucocorticoids long term to treat immune-mediated diseases. However, glucocorticoids, such as prednisone, have a side effect—they induce the bone loss called osteoporosis, ...

Bariatric surgery successes lead to type 2 diabetes treatment

April 24, 2018
Bariatric surgery has long yielded almost immediate health benefits for patients with type 2 diabetes, and new findings on the reasons for remission may be the key to developing drug alternatives to surgery.

Hacking human 'drug trafficking' network could make diabetes treatments more effective

April 23, 2018
Making tiny changes to existing diabetes treatments can alter how they interact with cells, and potentially make the medicines more effective.

Vitamin D deficiency linked to greater risk of diabetes

April 19, 2018
An epidemiological study conducted by researchers at University of California San Diego School of Medicine and Seoul National University suggests that persons deficient in vitamin D may be at much greater risk of developing ...

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

April 17, 2018
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.